Tinidazole
- Generic Name
- Tinidazole
- Brand Names
- Tindamax
- Drug Type
- Small Molecule
- Chemical Formula
- C8H13N3O4S
- CAS Number
- 19387-91-8
- Unique Ingredient Identifier
- 033KF7V46H
Overview
A nitroimidazole antitrichomonal agent effective against Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia infections.
Background
A nitroimidazole antitrichomonal agent effective against Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia infections.
Indication
For the treatment of trichomoniasis caused by T. vaginalis in both female and male patients. Also for the treatment of giardiasis caused by G. duodenalis in both adults and pediatric patients older than three years of age and for the treatment of intestinal amebiasis and amebic liver abscess caused by E. histolytica in both adults and pediatric patients older than three years of age.
Associated Conditions
- Amebiasis
- Bacterial Vaginosis (BV)
- Giardiasis
- Mixed Vaginal Infections
- Nongonococcal urethritis
- Sexually Transmitted Disease (STD)
- Trichomonas Vaginalis Infection
- Trichomonas Vaginitis
- Vaginal Candidiasis
Clinical Trials
FDA Approved Products
Tindazole
Manufacturer:Rising Pharma Holdings, Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2023/06/21
NDC:64980-427
Tinidazole
Manufacturer:Edenbridge Pharmaceuticals LLC.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2022/01/31
NDC:42799-208
Tinidazole
Manufacturer:Edenbridge Pharmaceuticals LLC.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2022/01/31
NDC:42799-207
Tinidazole
Manufacturer:Lupin Pharmaceuticals,Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2019/11/13
NDC:43386-550
Tinidazole
Manufacturer:RPK Pharmaceuticals, Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2019/12/23
NDC:53002-1611
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath